Tian, Xinlun
Yang, Yanli
Chen, Lulu
Sui, Xin
Xu, Wenshuai
Li, Xue
Guo, Xiaobei
Liu, Lingshan
Situ, Yusen
Wang, Jun
Zhao, Yang
Meng, Shuzhen
Song, Wei
Xiao, Yonglong
Xu, Kai-Feng
Funding for this research was provided by:
National Basic Research Program of China (2016YFC0901502)
National Natural Science Foundation of China (81570061)
the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (2017-12M-2-001, 2018-12M01-003)
Article History
Received: 18 March 2020
Accepted: 23 June 2020
First Online: 2 July 2020
Ethics approval and consent to participate
: The study was approved by the institutional review board of PUMCH (Approval No. S-717) and reviewed by the institutional review boards at the Affiliated Drum Tower Hospital of Nanjing University Medical School. All participants gave informed written consent prior to enrollment.
: Consent for publication was obtained from all participants.
: This work was supported partly by the North China Pharmaceutical Corporation (NCPC) and Beijing Yikang Healthcare Technology Co. Ltd. Both companies were not involved in the data analysis and interpretation. The drug was donated by NCPC.